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Haemostasis 3: 142-148 (1974\
Different Properties of Factor YIII in Von Willebrand's
Disease with Respect to Recoyery in Cryoprecipitate
J. Srrnnn, P.M. vaN lnn Pres and H.C. Hnurrn
Department of Hematology, Division of Hemostasis, Erasmus University, Rotterdam, and
Laboratory of Cardiovascular and Blood Coagulation Biochemistry, Department of
Internal Medicine, University Medical Centre, Leiden
Keywords. Von Willebrand's disease . Hemophilia-A ' Factor VIII ' Factor VIII-
related antigen' Bleeding factor' Cryoprecipitate
Abstract. The recovery of factor Vlll-activity in cryoprecipitate prepared from plasma
from six patients with von Willebrand's disease was low as compared to the recovery from
normal and hemophilia-A plasma. The possible cause is briefly discussed.
Using a standardized method to prepare cryoprecipitate from small
plasma samples it was found that the recovery of factor Vlll-activity
(F.VIII-act.) was low from plasma collected from patients with von Wille-
brand's disease (vwd). The results are reported and discussed.
Materials and Methods
Platelet-poor plasma (PPP).S ml of blood was collected into polystyrene tubes
containing 0.1 ml sodium citrate 0.55 tu, centrifuged immediately (10 min, 1,000 g, room
temperature) the plasma separated and centrifuged again (25 min, 20.000 Sr, 4'C).
Preparation of cryoprecipitare. Immediately after the second centrifugation run, 2-ml
samples ofPPP were pipetted into polycarbonate centrifuge tubes, quickly frozen at -30 'C
in an ethanol/water mixture, stoppered and stored at -70"C for l1 days. The samples
were then thawed for I h at 2"Cin a continuously stirred ethanol/water mixture. (Pre-
liminary experiments showed that thawing for 45-120 min gave reproducible results.) The
tubes were then centrifuged (15 min, 20,A00 g,2'C) and the supernatant poured off.
Remnants of supernatant were carefully removed with filter paper. The cryoprecipitate
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Frg. ,1. Recovery of F. vIII-act. in cryoprecipitate prepared from normal, hemophilia-A
and vw plasma. Proven carriers of hemophilia-A, who were known to have a low F.vr[-
act. and patients with cardiovascular disease known to have a high F.vllr-act. were
included to obtain a continuous scale of F,vIII-act. in the plasmas studied. o : Normals;j : patients with cardiovascular diseases; t : hemophilia-A; tr : carriers of hemo-
philia-A; v: von Willebrand's disease.
was dissolved in 0.4 ml veronal bufrer (pH 7,42). In 8 duplicate preparations of cryoprec!
pitate of plasma (4 vwd and 4 normals) the mean error of recovery was4.6y", F.vrll-act.
in supernatant and cryoprecipitate were measured immediately.
Factor vlll-related antigen(F.VIII-RA) was measured by the Laurell technique using
rabbit anti-human factor vIII antiserum (Nordic, Tilburg). pooled normal plasma was
used as a standard. F. vIII-act. was assayed according to vnrrr,tMp et al.ll4las modified
byYnrrlle.etal.llsl,Bleedingtimeaccordingtolw[3]. Retentionofplnteletsinaglass-
fud column was measured according to S^qLzMAN [8].
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Fig. 2a.Recovery of F.VIII-act' in cryoprecipitate prepared from 
plasma of normals'
patientswithcardiovas"ol-di'"u'",hemophilia-A'carriersofhemophilia-AandvWd
(samedataasshowninngurel).bTheindividualresultsinvWdareshown.R.v.d.V.
and G.W. were studied on several occasions' R'A' and M'K' 
are mother and daughter'
the other Patients are unrelated'
Results
Recovery of F. VIII-act' in cryoprecipitate prepared from- vW 
plasma
was found to be low as compa'red io th. r""ou"ry from plasma from 
normals
aoa n"mopniUa-A patients (fig' 1, 2a), The F'VI[-act' left in the supernatant
was correspondingly higher ii vWa (table I)' There was no correlation be-
tween the F.vllr-act. in the originar plasma and the recovery 
of it in the
cryoprecipitate (ng. 1). In figure 2b lhe recovery of F' VIII-act' in cryopreci-
pitate is shown ,"pur*ty io' 
"u"h 
of the six vW patients studied' All vW
patients had low F.vrll-act. (see fig.1), a strongly prolonged bleeding time
and a low retention of piut"tttt in the glassbead column' G'W' once 
showed
a normal F.vIII_act. io n"'plasma (135% of normal) when she had an
infectious disease. F.VIII-RAwas measured in cryoprecipitate 
and super-
natant (table I). ln no instance could F'VIII-RA be measured in the super-
nalant. In cryoprecipitate the ratio biological activity/F'VIII-RA 
ranged
from 0.7 to 1.4.
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Table L F.VIII-act. and F.VIII-RA in cryoprecipitate and its supernatant prepared
from 6 vW patients (same cryoprecipitates as shown in figures 1 and,2)
Patient Cryoprecipitate Supernatant
F.VIII-act. F.VIII-RA
\ofnormal \ofnormal
t45
ratio
F.VIII-act
F.VIII-RA
F.VIII-act. F.VIII-RA
lofnormal lofnormal
R.v.d.V.
G.W.
M.K.
R.A.
o.B.
w.s.
57
42
304
80
50
42
42
48
60
49
65
NM
30
230
NM
NM
NM
60
80
75
90
t .o
1 .3
o.t
0.8
0.7
0.7
8
it
t4
it
32
22
)'
NM
"t
NM
NM
NM
The cryoprecipitates are dissolved in li5th the volume of the original plasma. In some
of the cryoprecipitates the F.VIII-RA could not be measured, which may be due to the
fact that the precipitation peaks of vW cryoprecipitates were often faint as compared to
the standard (normal plasma). NM : Not measurable.
Discussion
There is accumulating evidence that F.VIII-act. is bound to more than
one molecular form ll, Z, 4, '7, 9, 10, 12, 13, 16, l7l although it is question-
able whether (part of) these reported forms reflect the native state of F. VIII.
In former experiments it was found by us that F.VIII-act. in plasma in
vitro drops to about 501 of its initial value in about 10 h while during the
following 4 days practically no further drop in activity was seen UO, l2l.
The results were interpreted in this manner that F. VIII-act. was bound to
two molecular forms which were interdependentfl2l. One form then is labile
(or converted to the other form in vitro), while the other is quite stable. In
some patients with vWd the initial drop in F.VIII-act. was higher, being
about 7Ol of the initial value. This was true for their own as well as trans-
fusion-induced F.VIII-act. [0] suggesting different properties of F.VIII in
those vW patients investigated as compared to normal F.VIII.
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Wsrss and KocHwl' [16] reported that normal plasma contained two
molecular forms of F.Vru, a l'ower and a higher molecular weight 
form'
while cryoprecipitate only contained the high molecular weight 
form' These
results, combined with the finding that the F.vIII-act. in cryoprecipitate 
in
comparable conditions as in plasma (normal cryoprecipitate dissolved in
hemophilia-A plasma) is fairly stable [1i] led us to assume that this high
molecularweightformofF.Vll lmightberelatedoridenticalwiththeform
whichwasrecognizedbyusasstable.Followingthisreasoningandtogether
with our former flnding in vWd, differences in cryoprecipitation 
of vW
plasma were to expected. In fact, low recovery of F' VIII-act' and 
F' VIII-RA
in several vW patients were reported [5]' Cryopecipitates were made under
standardized conditions of six patients with vWd 
- several of them on
different occasions - and compared with normars and hemophilia-A 
patients.
In the vW patients the recovery was distinctly lower'
These results may be explained on basis of a hypothesis on 
the synthesis
of F.VI[ and the Bleeding factor (or von Willebrand factor) which was
proposed by us in 1967 t10l to account for our finding that in 
vitro about
50/, of the F.VIII-act. aisappears quickly while the remaining 
activity is
stable [10, 12] andat the same time could explain all phenomena seen 
in vWd
una nemopttitia-A. It was assumed that F'VIII was composed 
of two
subunits, i. e. subunit ot (a for hemophilia-'4)' deficient or defective in hemo-
pttitiu-e-urrO subunit p (p for Bleeding factor)' deficient or defective in vWd'
Subunits a' and p are coded by a gene on the X or an autosomal 
chromosome
respectively. Subunit p regulates the rate of synthesis or at leastthe 
release
ofsubuni ta.TheBleedir r -gfactoract iv i tywassupposedtoresideontheB
subunit. The F.VIII-RA as described later [18] was thought to be identical
wi ththepsubuni t .F.VI I I -act .maybeboundtothefreeasubuni t , thecom-
bined oc and p subunit and/or polymers of it (arrp*)1, thus explaining the
existenceoftwo(ormore)interdependentmoleculesshowingF.Vll l-act.Re.
cently a hypothesis has been proposed b yBt-ooxr et a/' [1] which has many simi-
larities to ours. The high molecular weight and low molecular weight 
subunits
in their hypothesis being comparable to our p and a subunit' respectively'
A deficient or defective p subunit - resulting in some type of vwd 
- may
changetherelativeconcentrationsofthedifferentformsofbiologicalactive
F.v l l l ,ora l ternat ive lychangethespeci f icb io logicalF.Vl l l -act .ofone
form, resulting in differlnt recovery of the F' VIII-act' in cryoprecipitate' 
All
vW patients investigated by us belonged to the same type of vW with 
regard
to low F.VIII-act., strongly prolonged bleeding time and low retention 
of
platelets in the glassbead column'
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The recovery of F.VIII-RA in cryoprecipitate may depend on the type
of vWd, namely the kind of defect of p subunit or deficiency of it. KBnNor,r,
et al . 16l reported a consistent low recovery of F. VIII-RA in cryoprecipitate
prepared from plasma of one patient with vWd as compared to normal and
hemophilia-A plasma. F.VIII-act. was not measured In five other vW
patients the results were found to be more variable with what was thought
to be probably due to the difficulty measuring low levels of F.VIII-RA. In
our vW patients the ratio biological F.YIII-acI./F.VIII-RA in the cryo-
precipitate ranged from 0.7 to 1.4 (table I). Whether this broad range repre-
sents real differences or is due to technical difficulties is not known. One
might expect that differences in molecular form will be reflected in the ratio
biological activity/F.VIII-RA. It has to be recognized, however, that differ-
ent molecular forms may differ in specific biological F.VIII-act. Further-
more, it is not known what fraction of the total B subunit (i.e. of the total
F.VIII-RA measured) occurs in a state not related to F.VIII-act., e.g. free
andlor bound to inactivated oc subunits. On the other hand, in the active
(o'f-), form, antigenic determinants of the p subunit may be concealed.
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